Amgen is a global biotech leader specializing in biologic medicines for oncology, nephrology, and inflammatory diseases. Its differentiators include decades of expertise in recombinant protein therapies. Amgen Canada, headquartered in Mississauga, supports commercialization, medical education, and clinical trials. Canadian operations also include partnerships with hospitals and research networks to advance care and access to biologics. Amgen employs professionals across medical, regulatory, and commercial functions nationwide.